Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.
Condition: Advanced Gastric Carcinoma Interventions: Drug: Trastuzumab; Drug: Oxaliplatin; Drug: Capecitabine Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
Conditions: HER2-positive Advanced Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma Intervention: Drug: Trastuzumab deruxtecan Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials
